Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Otilonium Bromide in Upper Gastrointestinal Endoscopy
NCT02576340Phase 4Completed
- Sponsor
- Konya Meram State Hospital
- Start
- Jan 2013
- Primary completion
- May 2013
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of otilonium, sponsored by Konya Meram State Hospital. Primary endpoint: Gastrointestinal Motility at 3 months. Started Jan 2013; status: completed.
02
Drugs
otilonium
Beyond the preview
Go deeper on NCT02576340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02576340.